Institutions Holding Call Options on Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the call option holders of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the institutions that hold call options on the stock, with a total of 13 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $478 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rangeley Capital, LLC
New Canaan, CT |
Feb 12, 2025 Q4 2024 |
5,000
calls
|
$184,250
0.12% of portfolio
|
Q4 2024
New holding
|
|
|
Persistent Asset Partners LTD
Hong Kong, K3 |
Feb 14, 2025 Q4 2024 |
572
calls
|
$21,078
0.22% of portfolio
|
Q4 2024
New holding
|
|
|
Fny Investment Advisers, LLC
|
Jan 13, 2025 Q4 2024 |
89
calls
|
$3,279
0.0% of portfolio
|
Q4 2024
Added 81.63%
|